The Problem with Self-Assessment
When a manufacturer tests its own product and issues the resulting certificate, it is performing a self-assessment. The organisation that profits from a sale also produces the document that validates the quality of what it sells. This is a textbook conflict of interest, and it is a problem that affects quality certification across many industries — not just research peptides.
In the research peptide market, this conflict is particularly acute because there is no mandatory external oversight. Licensed medicines undergo pre-market testing by regulatory bodies or independently verified contract manufacturers, and batch release is subject to external review. Research peptides operating in the grey market have no equivalent regulatory check. The only available quality assurance is whatever the supplier chooses to provide — which makes the independence of that assurance the critical variable.
When a supplier provides a COA from their own laboratory, or from a laboratory that shares ownership, branding, or personnel with the selling organisation, that document cannot be treated as independent evidence of quality. It may be technically accurate, or it may not. Without independence, there is no way to know.
What Does "Independent" Actually Mean?
An independent laboratory, in the context of research peptide testing, is one that:
- Has no ownership, equity, or financial relationship with the supplier whose products it tests
- Does not share physical premises, staff, or management with the supplier
- Operates as a standalone commercial testing service, available to any client on equivalent terms
- Issues results based on its analytical findings alone, without reference to the supplier's preferred outcome
- Holds its accreditation independently of any commercial relationship with specific clients
A laboratory that is listed as a subsidiary, a sister company, or a "testing division" of a peptide supplier does not meet this standard. A laboratory that tests exclusively or near-exclusively for a single supplier may have practical independence issues even if it is formally separate.
ISO/IEC 17025 — The International Standard
ISO/IEC 17025 is the international standard that specifies the general requirements for the competence of testing and calibration laboratories. Published by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC), it is recognised by accreditation bodies in over 100 countries and represents the global benchmark for laboratory quality.
The standard covers two main domains: management requirements (the laboratory's quality management system, document control, corrective actions, and audit processes) and technical requirements (personnel competence, equipment calibration, measurement traceability, sampling procedures, and testing methodology). A laboratory accredited to ISO/IEC 17025 has had its processes externally assessed against both domains and found to meet the standard.
Importantly, accreditation to ISO/IEC 17025 is scope-specific. A laboratory may hold accreditation for certain testing methods but not others. When evaluating a peptide COA, check that the accreditation scope includes the specific methods used — HPLC for purity determination and LC-MS for identity confirmation. A laboratory accredited for food testing, for instance, may not hold accreditation for the specific analytical chemistry methods relevant to peptide purity.
UKAS — The UK National Accreditation Body
In the United Kingdom, the national accreditation body is UKAS — the United Kingdom Accreditation Service. UKAS is a government-appointed organisation, operating under the Accreditation Regulations 2009, that assesses and accredits laboratories against ISO/IEC 17025 (and other standards for different types of conformity assessment bodies).
UKAS maintains a publicly searchable online register of all currently accredited organisations at ukas.com. The register can be searched by organisation name, location, or accreditation number. If a laboratory claims UKAS accreditation, its name and accreditation number should appear in this register with an active status. If it does not, the claim cannot be verified.
A UKAS accreditation number typically takes the form of a four-digit number (e.g., "UKAS Testing 1234"). This number should appear on the COA or be verifiable by contacting the laboratory directly. Reputable laboratories routinely include their accreditation reference on issued documentation.
Step 1: Note the laboratory name and accreditation number from the COA.
Step 2: Search the UKAS register at ukas.com for the laboratory name and accreditation number.
Step 3: Confirm the accreditation is current (not expired or suspended) and covers the relevant testing methods (HPLC, LC-MS).
Step 4: Search for any corporate connection between the laboratory and the supplier — company register filings, shared directors, and shared addresses are all verifiable via Companies House (companieshouse.gov.uk).
Step 5: If uncertain, contact the laboratory directly using contact information found on its own website (not the supplier's website) to confirm it tested the specific batch.
Why UK-Based Testing Is Not Always Necessary
Some credible suppliers use third-party laboratories based in other countries — particularly the United States, Germany, or other EU member states — that hold equivalent accreditation under their national accreditation bodies (e.g., A2LA in the US, DAkkS in Germany). These are internationally recognised equivalents to UKAS under the International Laboratory Accreditation Cooperation (ILAC) mutual recognition arrangement.
The key requirement is not that the laboratory be based in the UK, but that it holds internationally recognised accreditation for the relevant testing methods, is demonstrably independent of the supplier, and issues batch-specific COAs with full methodology disclosure.
What Good Laboratory Documentation Looks Like
A COA from a genuinely independent, accredited laboratory will typically include: the laboratory's name, address, and accreditation reference on a letterhead; the client's name and order reference; the compound name, CAS number, and batch number; the test method (HPLC for purity, LC-MS for identity); the results with appropriate significant figures; the analyst's reference or signature; the date of analysis; and a statement of the accreditation under which the analysis was conducted.
Documents that lack several of these elements, or that use layout and formatting identical to the supplier's own marketing materials, are a concern. A credible laboratory produces documentation according to its own quality management system, not according to a template provided by its client.
The Medical Consultation Is Still Required
Understanding laboratory independence is essential context for evaluating research peptide sources. It does not, however, substitute for a consultation with a licensed healthcare professional. The quality of a compound's documentation is distinct from the question of whether that compound is appropriate for any specific individual — a question that requires medical knowledge, health history, and professional judgement that no COA can provide.
Always consult a licensed GP or specialist before making any decision about a research peptide.